These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 2588923

  • 41. Chromosome analysis in effusions as a diagnostic adjunct to cytology.
    Augustus M, Visveshwara RN, Bhargava MK.
    Indian J Cancer; 1989 Jun; 26(2):67-75. PubMed ID: 2592000
    [Abstract] [Full Text] [Related]

  • 42. [Pleural and subsequent peritoneal effusions of pancreatic origin. Pleural talc treatment as a cause?].
    Mouroux J, Benchimol D, Bernard JL, Lemoigne F, Clary-Meinesz C, Blaive B, Bourgeon A, Richelme H.
    Rev Mal Respir; 1991 Jun; 8(5):499-500. PubMed ID: 1767123
    [Abstract] [Full Text] [Related]

  • 43. Extramedullary hematopoietic effusions.
    García-Riego A, Cuiñas C, Vilanova JJ, Ibarrola R.
    Acta Cytol; 1998 Jun; 42(5):1116-20. PubMed ID: 9755667
    [Abstract] [Full Text] [Related]

  • 44. [Intrapleural administration with OK-432 and cultured autologous pleural effusion lymphocytes for breast cancer patients with malignant pleural effusions: analysis of 84 patients over a 14-year period].
    Kan N.
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1796-800. PubMed ID: 10560397
    [Abstract] [Full Text] [Related]

  • 45. Pleural effusions: role of commonly available investigations.
    How SH, Chin SP, Zal AR, Liam CK.
    Singapore Med J; 2006 Jul; 47(7):609-13. PubMed ID: 16810434
    [Abstract] [Full Text] [Related]

  • 46. Prevalence of human immunodeficiency virus infection: its impact on the diagnostic yields in exudative pleural effusions at the Kenyatta National Hospital, Nairobi.
    Owino EA, McLigeyo SO, Gathua SN, Nyong'o A.
    East Afr Med J; 1996 Sep; 73(9):575-8. PubMed ID: 8991236
    [Abstract] [Full Text] [Related]

  • 47. [Usefulness of CEA, CA 15-3 and CA 125 tumor markers in the differential diagnostics of peritoneal effusion].
    Kiluk MS, Rółkowski R, Zawadzki RJ, Wojtukiewicz MZ.
    Pol Merkur Lekarski; 2002 Oct; 13(76):298-301. PubMed ID: 12557435
    [Abstract] [Full Text] [Related]

  • 48. Cytogenetic analysis of effusions from malignant mesothelioma. A diagnostic adjunct to cytology.
    Granados R, Cibas ES, Fletcher JA.
    Acta Cytol; 1994 Oct; 38(5):711-7. PubMed ID: 8091903
    [Abstract] [Full Text] [Related]

  • 49. Prognostic value of visceral pleural invasion in resected non-small cell lung cancer diagnosed by using a jet stream of saline solution.
    Maruyama R, Shoji F, Okamoto T, Miyamoto T, Miyake T, Nakamura T, Ikeda J, Asoh H, Yamaguchi M, Yoshino I, Ichinose Y.
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1587-92. PubMed ID: 15173711
    [Abstract] [Full Text] [Related]

  • 50. [Recognition of tumorous and non-tumorous cells in cytological studies of serous fluids].
    Kurbatova TI.
    Vopr Onkol; 1968 Jun; 14(11):29-36. PubMed ID: 5729483
    [No Abstract] [Full Text] [Related]

  • 51. Distribution pattern of concanavalin A on carcinoma cells, histiocytes and mesothelial cells from effusions.
    Lubínski J.
    Acta Cytol; 1987 Jun; 31(2):99-103. PubMed ID: 3103357
    [Abstract] [Full Text] [Related]

  • 52. [Pleural effusion: diagnostic usefulness of pleural puncture biopsy].
    Ferreyra RA, Di Bartolo CG, Borgia A.
    Medicina (B Aires); 1989 Jun; 49(1):48-52. PubMed ID: 2630872
    [Abstract] [Full Text] [Related]

  • 53. [Pleuroperitoneal shunt for malignant pleural effusions].
    Sadahiro S, Tsumura O, Kubouchi K, Isobe Y, Ohmura T, Yamada Y, Saito T, Takeguchi K.
    Nihon Gan Chiryo Gakkai Shi; 1989 Jan 20; 24(1):1-6. PubMed ID: 2738435
    [Abstract] [Full Text] [Related]

  • 54. Sensitivity enhancement of the cytologic detection of cancer cells in effusions by monoclonal antibodies.
    Ménard S, Rilke F, Della Torre G, Mariani-Costantini R, Regazzoni M, Tagliabue E, Alasio L, Colnaghi MI.
    Am J Clin Pathol; 1985 May 20; 83(5):571-6. PubMed ID: 3887893
    [Abstract] [Full Text] [Related]

  • 55. [Therapy of malignant pleural effusions].
    Bruntsch U.
    MMW Munch Med Wochenschr; 1979 Sep 21; 121(38):1207-8. PubMed ID: 117306
    [No Abstract] [Full Text] [Related]

  • 56. Malignancies in Pleural, Peritoneal, and Pericardial Effusions.
    Dermawan JKT, Policarpio-Nicolas ML.
    Arch Pathol Lab Med; 2020 Sep 01; 144(9):1086-1091. PubMed ID: 31913661
    [Abstract] [Full Text] [Related]

  • 57. Malignant effusions and their management.
    Zehner LC, Hoogstraten B.
    Semin Oncol Nurs; 1985 Nov 01; 1(4):259-68. PubMed ID: 3854237
    [No Abstract] [Full Text] [Related]

  • 58. Pleural fluid pH in malignant effusions. Diagnostic, prognostic, and therapeutic implications.
    Sahn SA, Good JT.
    Ann Intern Med; 1988 Mar 01; 108(3):345-9. PubMed ID: 3341671
    [Abstract] [Full Text] [Related]

  • 59. Decreased glucose concentration in malignant pleural effusions.
    Berger HW, Maher G.
    Am Rev Respir Dis; 1971 Mar 01; 103(3):427-9. PubMed ID: 5152727
    [No Abstract] [Full Text] [Related]

  • 60. [Cytological variations observed in the malignant cells in body cavity fluids].
    Matsuda M.
    Rinsho Byori; 1990 Nov 01; Suppl 87():69-85. PubMed ID: 2287091
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.